|  Help  |  About  |  Contact Us

Publication : The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer.

First Author  Döppler H Year  2016
Journal  Sci Rep Volume  6
Pages  33758 PubMed ID  27649783
Mgi Jnum  J:299314 Mgi Id  MGI:6223166
Doi  10.1038/srep33758 Citation  Doppler H, et al. (2016) The PRKD1 promoter is a target of the KRas-NF-kappaB pathway in pancreatic cancer. Sci Rep 6:33758
abstractText  Increased expression of PRKD1 and its gene product protein kinase D1 (PKD1) are linked to oncogenic signaling in pancreatic ductal adenocarcinoma, but a direct functional relationship to oncogenic KRas has not been established so far. We here describe the PRKD1 gene promoter as a target for oncogenic KRas signaling. We demonstrate that KRas-induced activation of the canonical NF-kappaB pathway is one mechanism of how PRKD1 expression is increased and identify the binding sites for NF-kappaB in the PRKD1 promoter. Altogether, these results describe a novel mechanism governing PRKD1 gene expression in PDA and provide a functional link between oncogenic KRas, NF-kappaB and expression of PRKD1.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

9 Bio Entities

Trail: Publication

0 Expression